1. Home
  2. BRUN vs AAPG Comparison

BRUN vs AAPG Comparison

Compare BRUN & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boost Run Inc. Class A Common Stock

BRUN

Boost Run Inc. Class A Common Stock

N/A

Current Price

$16.62

Market Cap

1.4B

Sector

Technology

ML Signal

N/A

Logo Ascentage Pharma Group International American Depository Shares

AAPG

Ascentage Pharma Group International American Depository Shares

HOLD

Current Price

$16.70

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRUN
AAPG
Founded
N/A
2009
Country
United States
China
Employees
N/A
767
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
2026
2024

Fundamental Metrics

Financial Performance
Metric
BRUN
AAPG
Price
$16.62
$16.70
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$48.40
AVG Volume (30 Days)
2.4M
5.6K
Earning Date
N/A
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$290.34
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.56
$16.23
52 Week High
$40.46
$40.70

Technical Indicators

Market Signals
Indicator
BRUN
AAPG
Relative Strength Index (RSI) 40.40 42.67
Support Level $16.34 $16.56
Resistance Level $20.91 $18.45
Average True Range (ATR) 1.68 0.37
MACD 0.12 -0.01
Stochastic Oscillator 14.81 17.60

Price Performance

Historical Comparison
BRUN
AAPG

About BRUN Boost Run Inc. Class A Common Stock

Boost Run Inc is an NVIDIA Cloud Provider. Its platform provides GPU compute, CPU nodes, managed Kubernetes orchestration, and shared storage through an intuitive management console and a robust API layer, enabling organizations to provision and scale resources across thousands of nodes in minutes. Enterprises rely on Boost Run to power their main demanding AI workloads with the performance, security, and reliability their operations require. The group maintains SOC 2 Type II, HIPAA, ISO 27001, and ISO 27701 certifications at the operator level, and partners with data center facilities that uphold equivalent security and compliance standards.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: